High anaplastic lymphoma kinase immunohistochemical staining in neuroblastoma and ganglioneuroblastoma is an independent predictor of poor outcome

American Journal of Pathology

Volumn 180, Issue 3, 2012, Pages 1223-1231

  Duijkers, Floor A M ^a   Gaal, Joś ^b   Meijerink, Jules P P ^a   Admiraal, Pieter ^a   Pieters, Rob ^a   De Krijger, Ronald R ^b   Van Noesel, Max M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE; GENE MUTATION; GROUPS BY AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MYCN GENE; NERVE CELL; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; FEMALE; GANGLIONEUROBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; POINT MUTATION; PROGNOSIS; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 84857202050     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.12.003     Document Type: Article

References (45)

1. R.J. Deyell, E.F. Attiyeh Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma Cancer Genet 204 2011 113 121
2. E. Michels, J. Vandesompele, K. De Preter, J. Hoebeeck, J. Vermeulen, A. Schramm, J.J. Molenaar, B. Menten, B. Marques, R.L. Stallings, V. Combaret, C. Devalck, A. De Paepe, R. Versteeg, A. Eggert, G. Laureys, N. Van Roy, F. Speleman ArrayCGH-based classification of neuroblastoma into genomic subgroups Genes Chromosomes Cancer 46 2007 1098 1108
3. G.M. Brodeur Neuroblastoma: biological insights into a clinical enigma Nat Rev Cancer 3 2003 203 216
4. J.M. Maris The biologic basis for neuroblastoma heterogeneity and risk stratification Curr Opin Pediatr 17 2005 7 13
5. G.M. Brodeur, R.C. Seeger, M. Schwab, H.E. Varmus, J.M. Bishop Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage Science 224 1984 1121 1124
6. J.J. Molenaar, P. van Sluis, K. Boon, R. Versteeg, H.N. Caron Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma Genes Chromosomes Cancer 36 2003 242 249
7. H. Caren, F. Abel, P. Kogner, T. Martinsson High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours Biochem J 416 2008 153 159
8. Y. Chen, J. Takita, Y.L. Choi, M. Kato, M. Ohira, M. Sanada, L. Wang, M. Soda, A. Kikuchi, T. Igarashi, A. Nakagawara, Y. Hayashi, H. Mano, S. Ogawa Oncogenic mutations of ALK kinase in neuroblastoma Nature 455 2008 971 974
9. R.E. George, T. Sanda, M. Hanna, S. Frohling, W. Luther 2nd, J. Zhang, Y. Ahn, W. Zhou, W.B. London, P. McGrady, L. Xue, S. Zozulya, V.E. Gregor, T.R. Webb, N.S. Gray, D.G. Gilliland, L. Diller, H. Greulich, S.W. Morris, M. Meyerson, A.T. Look Activating mutations in ALK provide a therapeutic target in neuroblastoma Nature 455 2008 975 978
10. I. Janoueix-Lerosey, D. Lequin, L. Brugieres, A. Ribeiro, L. de Pontual, V. Combaret, V. Raynal, A. Puisieux, G. Schleiermacher, G. Pierron, D. Valteau-Couanet, T. Frebourg, J. Michon, S. Lyonnet, J. Amiel, O. Delattre Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma Nature 455 2008 967 970
11. Y.P. Mosse, M. Laudenslager, L. Longo, K.A. Cole, A. Wood, E.F. Attiyeh, M.J. Laquaglia, R. Sennett, J.E. Lynch, P. Perri, G. Laureys, F. Speleman, C. Kim, C. Hou, H. Hakonarson, A. Torkamani, N.J. Schork, G.M. Brodeur, G.P. Tonini, E. Rappaport, M. Devoto, J.M. Maris Identification of ALK as a major familial neuroblastoma predisposition gene Nature 455 2008 930 935
12. Y. Osajima-Hakomori, I. Miyake, M. Ohira, A. Nakagawara, A. Nakagawa, R. Sakai Biological role of anaplastic lymphoma kinase in neuroblastoma Am J Pathol 167 2005 213 222
13. L. Passoni, L. Longo, P. Collini, A.M. Coluccia, F. Bozzi, M. Podda, A. Gregorio, C. Gambini, A. Garaventa, V. Pistoia, F. Del Grosso, G.P. Tonini, M. Cheng, C. Gambacorti-Passerini, A. Anichini, F. Fossati-Bellani, M. Di Nicola, R. Luksch Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients Cancer Res 69 2009 7338 7346
14. A. Motegi, J. Fujimoto, M. Kotani, H. Sakuraba, T. Yamamoto ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth J Cell Sci 117 2004 3319 3329
15. C. Schonherr, H.L. Yang, M. Vigny, R.H. Palmer, B. Hallberg Anaplastic lymphoma kinase activates the small GTPase Rap1 via the Rap1-specific GEF C3G in both neuroblastoma and PC12 cells Oncogene 29 2010 2817 2830
16. T. Iwahara, J. Fujimoto, D. Wen, R. Cupples, N. Bucay, T. Arakawa, S. Mori, B. Ratzkin, T. Yamamoto Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system Oncogene 14 1997 439 449
17. J. Degoutin, N. Brunet-de Carvalho, C. Cifuentes-Diaz, M. Vigny ALK (anaplastic lymphoma kinase) expression in DRG neurons and its involvement in neuron-Schwann cells interaction Eur J Neurosci 29 2009 275 286
18. S.W. Morris, C. Naeve, P. Mathew, P.L. James, M.N. Kirstein, X. Cui, D.P. Witte ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK) Oncogene 14 1997 2175 2188
19. E. Vernersson, N.K. Khoo, M.L. Henriksson, G. Roos, R.H. Palmer, B. Hallberg Characterization of the expression of the ALK receptor tyrosine kinase in mice Gene Expr Patterns 6 2006 448 461
20. R. Li, S.W. Morris Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy Med Res Rev 28 2008 372 412
21. K. Pulford, L. Lamant, S.W. Morris, L.H. Butler, K.M. Wood, D. Stroud, G. Delsol, D.Y. Mason Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1 Blood 89 1997 1394 1404
22. S. De Brouwer, K. De Preter, C. Kumps, P. Zabrocki, M. Porcu, E.M. Westerhout, A. Lakeman, J. Vandesompele, J. Hoebeeck, T. Van Maerken, A. De Paepe, G. Laureys, J.H. Schulte, A. Schramm, C. Van Den Broecke, J. Vermeulen, N. Van Roy, K. Beiske, M. Renard, R. Noguera, O. Delattre, I. Janoueix-Lerosey, P. Kogner, T. Martinsson, A. Nakagawara, M. Ohira, H. Caron, A. Eggert, J. Cools, R. Versteeg, F. Speleman Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification Clin Cancer Res 16 2010 4353 4362
23. L. Lamant, K. Pulford, D. Bischof, S.W. Morris, D.Y. Mason, G. Delsol, B. Mariame Expression of the ALK tyrosine kinase gene in neuroblastoma Am J Pathol 156 2000 1711 1721
24. V. Willoughby, A. Sonawala, A. Werlang-Perurena, L.R. Donner A comparative immunohistochemical analysis of small round cell tumors of childhood: utility of peripherin and alpha-internexin as markers for neuroblastomas Appl Immunohistochem Mol Morphol 16 2008 344 348
25. J.H. Schulte, H.S. Bachmann, B. Brockmeyer, K. Depreter, A. Oberthr, S. Ackermann, Y. Kahlert, K. Pajtler, J. Theissen, F. Westermann, J. Vandesompele, F. Speleman, F. Berthold, A. Eggert, B. Brors, B. Hero, A. Schramm, M. Fischer High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma Clin Cancer Res 17 2011 5082 5092
26. C. Stock, E. Bozsaky, F. Watzinger, U. Poetschger, L. Orel, T. Lion, A. Kowalska, P.F. Ambros Genes proximal and distal to MYCN are highly expressed in human neuroblastoma as visualized by comparative expressed sequence hybridization Am J Pathol 172 2008 203 214
27. U. McDermott, A.J. Iafrate, N.S. Gray, T. Shioda, M. Classon, S. Maheswaran, W. Zhou, H.G. Choi, S.L. Smith, L. Dowell, L.E. Ulkus, G. Kuhlmann, P. Greninger, J.G. Christensen, D.A. Haber, J. Settleman Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors Cancer Res 68 2008 3389 3395
28. S. Umehara, A. Nakagawa, K.K. Matthay, J.N. Lukens, R.C. Seeger, D.O. Stram, R.B. Gerbing, H. Shimada Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular Cancer 89 2000 1150 1161
29. M. Peuchmaur, E.S. d'Amore, V.V. Joshi, J. Hata, B. Roald, L.P. Dehner, R.B. Gerbing, D.O. Stram, J.N. Lukens, K.K. Matthay, H. Shimada Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular Cancer 98 2003 2274 2281
30. H. Caron, P. van Sluis, M. van Hoeve, J. de Kraker, J. Bras, R. Slater, M. Mannens, P.A. Voute, A. Westerveld, R. Versteeg Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification Nat Genet 4 1993 187 190
31. F.A. Duijkers, J. Gaal, J.P. Meijerink, P. Admiraal, R. Pieters, R.R. de Krijger, M.M. van Noesel Anaplastic lymphoma kinase (ALK) inhibitor response in neuroblastoma is highly correlated with ALK mutation status, ALK mRNA and protein levels Cell Oncol (Dordr) 34 2011 409 417
32. R. Haupt, A. Garaventa, C. Gambini, S. Parodi, G. Cangemi, F. Casale, E. Viscardi, M. Bianchi, A. Prete, A. Jenkner, R. Luksch, A. Di Cataldo, C. Favre, P. D'Angelo, G.A. Zanazzo, G. Arcamone, G.C. Izzi, A.R. Gigliotti, G. Pastore, B. De Bernardi Improved survival of children with neuroblastoma between 1979 and 2005: a report of the Italian Neuroblastoma Registry J Clin Oncol 28 2010 2331 2338
33. J.R. Park, A. Eggert, H. Caron Neuroblastoma: biology, prognosis, and treatment Hematol Oncol Clin North Am 24 2010 65 86
34. C. Okamatsu, W.B. London, A. Naranjo, M.D. Hogarty, J.M. Gastier-Foster, A.T. Look, M. LaQuaglia, J.M. Maris, S.L. Cohn, K.K. Matthay, R.C. Seeger, T. Saji, H. Shimada Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG Pediatr Blood Cancer 53 2009 563 569
35. T. Reiff, L. Huber, M. Kramer, O. Delattre, I. Janoueix-Lerosey, H. Rohrer Midkine and Alk signaling in sympathetic neuron proliferation and neuroblastoma predisposition Development 138 2011 4699 4708
36. P. Mazot, A. Cazes, M.C. Boutterin, A. Figueiredo, V. Raynal, V. Combaret, B. Hallberg, R.H. Palmer, O. Delattre, I. Janoueix-Lerosey, M. Vigny The constitutive activity of the ALK mutated at positions F1174 or R1275 impairs receptor trafficking Oncogene 30 2011 2017 2025
37. K. Garber ALK, lung cancer, and personalized therapy: portent of the future? J Natl Cancer Inst 102 2010 672 675
38. Y.P. Mosse, A. Wood, J.M. Maris Inhibition of ALK signaling for cancer therapy Clin Cancer Res 15 2009 5609 5614
39. T.R. Webb, J. Slavish, R.E. George, A.T. Look, L. Xue, Q. Jiang, X. Cui, W.B. Rentrop, S.W. Morris Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy Expert Rev Anticancer Ther 9 2009 331 356
40. E. Ardini, P. Magnaghi, P. Orsini, A. Galvani, M. Menichincheri Anaplastic lymphoma kinase: role in specific tumours, and development of small molecule inhibitors for cancer therapy Cancer Lett 299 2010 81 94
41. T. Martinsson, T. Eriksson, J. Abrahamsson, H. Caren, M. Hansson, P. Kogner, S. Kamaraj, C. Schonherr, J. Weinmar, K. Ruuth, R.H. Palmer, B. Hallberg Appearance of the novel activating F1174S ALK mutation in neuroblastoma correlates with aggressive tumor progression and unresponsiveness to therapy Cancer Res 71 2011 98 105
42. K.L. Milkiewicz, G.R. Ott Inhibitors of anaplastic lymphoma kinase: a patent review Expert Opin Ther Pat 20 2010 1653 1681
43. F.C. Kelleher, R. McDermott The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene Eur J Cancer 46 2010 2357 2368
44. T. Bachetti, D. Di Paolo, S. Di Lascio, V. Mirisola, C. Brignole, M. Bellotti, I. Caffa, C. Ferraris, M. Fiore, D. Fornasari, R. Chiarle, S. Borghini, U. Pfeffer, M. Ponzoni, I. Ceccherini, P. Perri PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma PLoS One 5 2010 e13108
45. E.H. Raabe, M. Laudenslager, C. Winter, N. Wasserman, K. Cole, M. LaQuaglia, D.J. Maris, Y.P. Mosse, J.M. Maris Prevalence and functional consequence of PHOX2B mutations in neuroblastoma Oncogene 27 2008 469 476